Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06446661

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia Using Text Messages

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
15 Years – 39 Years
Healthy volunteers
Not accepted

Summary

The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).

Detailed description

This study aims to compare adherence to oral mercaptopurine and methotrexate during the first 84-day cycle of maintenance therapy for adolescent and young adult patients with Acute Lymphoblastic Leukemia on pediatric-based regimens between those who receive the high intensity text message intervention and those who receive standard-of-care. It is believed that high-intensity text messages will increase patient adherence within cycle 1.

Conditions

Interventions

TypeNameDescription
OTHERHigh IntensityDaily texts
OTHERNo Text MessagingsStandard Care
OTHERLow Intensity Text MessagingWeekly Texts

Timeline

Start date
2026-12-15
Primary completion
2027-06-15
Completion
2028-06-15
First posted
2024-06-06
Last updated
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06446661. Inclusion in this directory is not an endorsement.